检索结果 - Gil Redelman‐Sidi

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Could BCG be used to protect against COVID-19?

    Could BCG be used to protect against COVID-19? 由 Gil Redelman‐Sidi

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    BCG in Bladder Cancer Immunotherapy

    BCG in Bladder Cancer Immunotherapy 由 Song Jiang, Gil Redelman‐Sidi

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Rapidly Growing Mycobacteria Infection in Patients with Cancer

    Rapidly Growing Mycobacteria Infection in Patients with Cancer 由 Gil Redelman‐Sidi, Kent A. Sepkowitz

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy

    Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy 由 Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, Paul Elkington

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells

    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells 由 Gil Redelman‐Sidi, Gopa Iyer, David B. Solit, Michael S. Glickman

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways

    Mycobacteria exploit three genetically distinct DNA double‐strand break repair pathways 由 Richa Gupta, Daniel Barkan, Gil Redelman‐Sidi, Stewart Shuman, Michael S. Glickman

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling

    Bacterial immunotherapy for cancer induces CD4-dependent tumor-specific immunity through tumor-intrinsic interferon-γ signaling 由 Anthony C. Antonelli, Anna Binyamin, Tobias M. Hohl, Michael S. Glickman, Gil Redelman‐Sidi

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune ch... 由 Gil Redelman‐Sidi, Olivier Michielin, Carlos Cervera, Camillo Ribi, José María Aguado, Mario Fernández‐Ruiz, Oriol Manuel

    出版 2018
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer

    Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer 由 Tilly Varughese, Ying Taur, Nina Cohen, M. Lia Palomba, Susan K. Seo, Tobias M. Hohl, Gil Redelman‐Sidi

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma

    The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma 由 María del Carmen López Castillo, Fabián Andrés Rosas Romero, Esther Argüello, Chrisann Kyi, Michael A. Postow, Gil Redelman‐Sidi

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer

    The Canonical Wnt Pathway Drives Macropinocytosis in Cancer 由 Gil Redelman‐Sidi, Anna Binyamin, Isabella Gaeta, Wilhelm Palm, Craig B. Thompson, Paul B. Romesser, Scott W. Lowe, Mukta Bagul, John G. Doench, David E. Root, Michael S. Glickman

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Determinants of Severity in Cancer Patients with COVID-19 Illness

    Determinants of Severity in Cancer Patients with COVID-19 Illness 由 Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, C. Ortiz, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    出版 2020
    获取全文
    Pré-impressão
    加到收藏夹
    Saved in:
  13. 13
    Determinants of COVID-19 disease severity in patients with cancer

    Determinants of COVID-19 disease severity in patients with cancer 由 Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, Thierry Rolling, Rocío Pérez-Johnston, Marilia Bernardes, Yael Bogler, Mario Caldararo, Cesar J. Figueroa, Michael S. Glickman, Alexa Joanow, Anna Kaltsas, Yeon Joo Lee, Anabella Lucca Bianchi, Amanda Mariano, Sejal Morjaria, Tamara Nawar, Genovefa A. Papanicolaou, Jacqueline Predmore, Gil Redelman‐Sidi, Elizabeth Schmidt, Susan K. Seo, Kent A. Sepkowitz, Monika K. Shah, Jedd D. Wolchok, Tobias M. Hohl, Ying Taur, Mini Kamboj

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: